Fresenius Kabi USA, LLC

Form 483FOIA Uncovered

Grand Island, New York, United StatesFEI 3001833549Issued October 13, 2023

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3001833549.

Observations2

Issue DateOctober 13, 2023

StatusNo Warning Letter

Related Inspections10

Establishment Details

Firm: Fresenius Kabi USA, LLC
Location: Grand Island, New York, United States
FEI Number: 3001833549
Product Type: Drugs
Issue Date: October 13, 2023
Country: United States

Inspection History, 2011 to 2023

NAI1

VAI7

OAI2

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Fresenius Kabi USA, LLC FDA Form 483, Grand Island, New York, October 13, 2023